imatinib mesylate has been researched along with Leukocytosis in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (60.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Tian, ZG; Weng, LC; Xu, Y | 1 |
| Begna, K; Smith, CJ; Stewart, G | 1 |
| Chen, B; Yan, X; Yang, H; Zhang, X | 1 |
| Hoang, U; Khan, U; Mehta, VR; Rachshtut, M | 1 |
| Abdelmalek, C; Andrei, M; Bandarchuk, A; Gotlieb, V; Kundra, A; Wang, JC | 1 |
| Colovic, M; Pavlovic, S; Radojkovic, M; Ristic, S | 1 |
| Hackanson, B; Lübbert, M; Rückert, A | 1 |
| Baccarani, M; Dreyling, M | 1 |
| Guo, Y; Munoz, J | 1 |
| Atallah, E; Haddad, RY; Torgerson, SR | 1 |
| Apperley, JF; Bain, BJ; Baxter, EJ; Chase, A; Chessells, JM; Colombat, M; Cross, NC; Dearden, CE; Dimitrijevic, S; Gardembas, M; Goldman, JM; Mahon, FX; Marin, D; Melo, JV; Nikolova, Z; Olavarria, E; Russell-Jones, R; Schultheis, B; Silberman, S | 1 |
| Birgens, H; Bjerrum, OW; Clausen, NT; Hansen, PB; Hasselbalch, HC; Jensen, BA; Ralfkiaer, E; Therkildsen, MH | 1 |
| Al-Beirouti, B; Keating, A; Lipton, JH; McCrae, J; Messner, HA; Rifkind, J; Song, KW; Yee, K | 1 |
| Bastie, JN; Castaigne, S; Cross, NC; Garcia, I; Mahon, FX; Terré, C | 1 |
| Andersen, MK; Brondum-Nielsen, K; Dufva, IH; Johnsen, HE; Karle, H; Madsen, HO | 1 |
| Ozdemirli, M; Tutuncuoglu, SO; Yanovich, S | 1 |
| Higashi, T; Kubota, A; Matsuura, A; Mizobe, T; Morimoto, H; Mouri, F; Ohta, T; Sugito, M; Tanaka, Y; Tsukada, J | 1 |
| Heaney, NB; Holyoake, TL | 1 |
| Bona, R; Kaplan, AA; Shafique, S | 1 |
| Chao, K; Kyathari, S; Liu, D; Seiter, K | 1 |
6 review(s) available for imatinib mesylate and Leukocytosis
| Article | Year |
|---|---|
A rare cause of persistent leukocytosis with massive splenomegaly: Myeloid neoplasm with BCR-PDGFRA rearrangement-Case report and literature review.
Topics: Adult; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Myeloproliferative Disorders; Splenomegaly | 2022 |
Leukostasis retinopathy: An uncommon visual threatening complication of chronic myeloid leukemia with severe hyperleukocytosis - A case report and review of the literature.
Topics: Antineoplastic Agents; Blindness; Combined Modality Therapy; Humans; Imatinib Mesylate; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Leukostasis; Male; Retinal Diseases; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2018 |
PDGFRᵝ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review.
Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Dose-Response Relationship, Drug; Eosinophilia; Gene Rearrangement; Humans; Imatinib Mesylate; Leukocyte Count; Leukocytosis; Male; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Receptor, Platelet-Derived Growth Factor alpha; Treatment Outcome | 2017 |
Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Disease Progression; Fatal Outcome; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Leukocytosis; Male; Monosomy; Philadelphia Chromosome; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Selection, Genetic | 2009 |
Chronic myelogenous leukemia for primary care physicians.
Topics: Benzamides; Biopsy, Fine-Needle; Bone Marrow; Dasatinib; Disease Progression; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Philadelphia Chromosome; Piperazines; Platelet Count; Pregnancy; Pregnancy Complications, Neoplastic; Primary Health Care; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Translocation, Genetic | 2012 |
What is new in chronic myeloid leukaemia?
Topics: Antineoplastic Agents; Aurora Kinases; Benzamides; Bone Marrow Transplantation; Dasatinib; Drug Resistance, Neoplasm; Hepatomegaly; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Piperazines; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrimidines; Splenomegaly; Thiazoles | 2007 |
1 trial(s) available for imatinib mesylate and Leukocytosis
| Article | Year |
|---|---|
Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Female; Humans; Hydroxyurea; Imatinib Mesylate; Interferon-alpha; Leukocytosis; Male; Middle Aged; Piperazines; Polycythemia; Primary Myelofibrosis; Pyrimidines; Thrombocytosis; Treatment Outcome | 2003 |
13 other study(ies) available for imatinib mesylate and Leukocytosis
| Article | Year |
|---|---|
44-Year-Old Man With Fatigue, Weight Loss, and Leukocytosis.
Topics: Adult; Basophils; Diagnosis, Differential; Exercise Tolerance; Fatigue; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Leukocytosis; Male; Protein Kinase Inhibitors; Treatment Outcome; Weight Loss | 2021 |
Killing two birds with one stone: a case of GIST and supervening CML.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Middle Aged; Neoplasms, Multiple Primary | 2015 |
Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis.
Topics: Adult; Antineoplastic Agents; Benzamides; Electrophoresis, Agar Gel; Genes, abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Topics: Benzamides; Cytogenetic Analysis; Europe; Follow-Up Studies; Humans; Imatinib Mesylate; Immunotherapy; In Situ Hybridization, Fluorescence; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Neoplasm Staging; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Thrombocytosis; Treatment Outcome | 2010 |
Leukocytosis: the mysteries within.
Topics: Aged; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Leukocytosis; Male; Piperazines; Pyrimidines; Remission Induction | 2012 |
Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
Topics: Adult; Aged; Benzamides; Child; Chromosomes, Human, Pair 5; DNA-Binding Proteins; Eosinophilia; ETS Translocation Variant 6 Protein; Gene Rearrangement; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukocytosis; Male; Middle Aged; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-ets; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Repressor Proteins | 2002 |
Subdural hematomas during CML therapy with imatinib mesylate.
Topics: Aged; Antineoplastic Agents; Benzamides; Blast Crisis; Female; Hematoma, Subdural; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Middle Aged; Piperazines; Pyrimidines; Remission Induction; Risk Factors; Thrombocytopenia; Treatment Outcome | 2004 |
Lack of response to imatinib mesylate in a patient with accelerated phase myeloproliferative disorder with rearrangement of the platelet-derived growth factor receptor beta-gene.
Topics: Benzamides; Biomarkers; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 5; Disease Progression; Drug Resistance; Enzyme Inhibitors; Gene Rearrangement; Humans; Hydroxyurea; Imatinib Mesylate; Leukocytosis; Male; Middle Aged; Mutant Proteins; Oncogene Proteins, Fusion; Piperazines; Primary Myelofibrosis; Pyrimidines; Splenectomy; Splenomegaly; Thrombocytopenia; Translocation, Genetic; Treatment Failure | 2004 |
Chronic myeloid leukaemia with BCR-ABL fusion genes located to both chromosomes 9, cyclic leukocytosis and nodal T-lymphoblastic transformation--durable complete remission following imatinib therapy.
Topics: Antineoplastic Agents; Benzamides; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 9; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Middle Aged; Piperazines; Pyrimidines; Remission Induction; T-Lymphocytes | 2005 |
CMV-induced hemorrhagic cystitis as a complication of peripheral blood stem cell transplantation: case report.
Topics: Benzamides; Biopsy; Bone Marrow; Cystitis; Cytomegalovirus; Hemoglobins; Humans; Imatinib Mesylate; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Piperazines; Platelet Count; Pneumonia; Pyrimidines; Time Factors; Transplantation Conditioning | 2005 |
[Generalized erythema triggered by a rapid decrease of basophils in chronic myeloid leukemia treated with imatinib].
Topics: Antineoplastic Agents; Basophils; Benzamides; Erythema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Leukopenia; Middle Aged; Piperazines; Pyrimidines; Severity of Illness Index | 2005 |
A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.
Topics: Adult; Antineoplastic Agents; Benzamides; Blood Viscosity; Chronic Disease; Humans; Imatinib Mesylate; Leukapheresis; Leukemia, Myeloid; Leukocytosis; Leukostasis; Male; Piperazines; Pyrimidines; Retinal Hemorrhage | 2007 |
Severe imatinib-associated muscle edema in patients with chronic myelogenous leukemia and marked leukocytosis.
Topics: Adult; Benzamides; Edema; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Magnetic Resonance Imaging; Muscle, Skeletal; Piperazines; Pyrimidines | 2008 |